Who
Amy McBride Wendell
Director
Company insider
Files Form 4 as: Director, Axogen; Director, Solventum; Director, Baxter International; Director, Hologic; Director, ChronoScale Holdings; Senior Vice President, Covidien.
In numbers
- Trades disclosed
- 258
- Buys
- 7
- Sells
- 16
- Bought
- $868K
- Sold
- $18.1M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 2 Jul 2007
- Last trade
- 11 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $198K13,353 at $14.85 | filing |
| 11 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $647K13,353 at $48.42 | filing |
| 11 Aug 2026filed 12 Aug 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —13,353 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —13,353 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $198K13,353 at $14.85 | filing |
| 11 Aug 2026filed 12 Aug 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $647K13,353 at $48.42 | filing |
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,392 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code A | —4,392 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 19 Jun 2026filed 23 Jun 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | —14,150 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,300 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | SOLV Solventumoption or derivative · Medical Devices | SEC FORM 4 Code A | —3,300 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $24K1,647 at $14.85 | filing |
| 8 May 2026filed 12 May 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $70K1,647 at $42.60 | filing |
| 8 May 2026filed 12 May 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,647 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | AXGN Axogenoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,647 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Code M | $24K1,647 at $14.85 | filing |
| 8 May 2026filed 12 May 2026 | AXGN AxogenMedical Devices | SEC FORM 4 Sold | $70K1,647 at $42.60 | filing |
News
Analyzing AxoGen (NASDAQ:AXGN) & RxSight (NASDAQ:RXST)AXGN · themarketsdaily.com · 22 Oct 2026Analyzing GE HealthCare Technologies (NASDAQ:GEHC) & AxoGen (NASDAQ:AXGN)AXGN · tickerreport.com · 21 Oct 2026Analyzing AxoGen (NASDAQ:AXGN) & AtriCure (NASDAQ:ATRC)AXGN · tickerreport.com · 18 Oct 2026
0 headlines in the last 90 days name Amy McBride Wendell; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.